2020 Annual Meeting - Prostate Cancer: Case Based Discussion
This course will discuss current clinical scenarios in prostate cancer with an expert panel discussing decision points starting from a patient case but expanding to include audience responses, the panel's opinion, and finally discussing the evidence and guidelines for each situation situation. In this 75-minute session there will be three 20 minute cases with 15 minutes for panel questions. The cases will be favorable intermediate risk SBRT vs. brachytherapy, post-op prostate treatment, and treatment of ultra high risk and oligometastatic patients.
The activity is designed to meet the interests of radiation oncologists, radiation physicists, and radiation oncology residents.
- Explain treatment techniques and patient selection.
- Apply the latest clinical data to patients in clinic and during multidisciplinary conferences.
- Thomas P. Boike, MD, MMM is employed at Michigan Healthcare Professionals and has no financial relationships with a commercial interest.
- Christopher Hays Pope, MD, CARTI is employed at Radiation Oncology Associates. P.A. and has no financial relationships with a commercial interest.
- Michael R. Folkert, MD, PhD is employed at Department of Radiation Oncology, University of Texas Southwestern Medical Center and has a research grant from Augmenix, Inc.
- Rahul D. Tendulkar, MD, is employed at Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic and receives compensation from Varian Medical Systems.
- Bridget F. Koontz, MD is employed at Duke Cancer Institute and has grants from Janssen Services LLC. Dr. Koonts has investment interest from Blue Earth Diagnostics.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
• No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
• No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
• ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.